Universal Starch-Chem Allied Limited

As of June 30, 2026, Universal Starch-Chem Allied Limited carries a market capitalization of 865.20M, placing it among publicly traded companies globally. Its enterprise value stands at 865.20M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Universal Starch-Chem Allied Limited has 4.20M shares outstanding.

As of June 30, 2026, Universal Starch-Chem Allied Limited trades at a trailing price-to-earnings ratio of 4.58.

As of June 30, 2026, Universal Starch-Chem Allied Limited trades at an EV/EBITDA multiple of 2.28 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.17 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 2.83 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 865.20M versus a market cap of 865.20M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 14.04M in revenue per employee across its workforce of 366.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Universal Starch-Chem Allied Limited recorded 64.23M in income tax expense. That works out to an effective tax rate of 25.38, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 253.08M, leaving 188.82M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Universal Starch-Chem Allied Limited's stock has gained approximately 41.30% over the past 52 weeks. The 50-day moving average sits at 197.40, while the 200-day moving average is 168.37.

Over the twelve months ended June 30, 2026, Universal Starch-Chem Allied Limited generated 5.15B in revenue and converted that into 188.82M in net income, yielding earnings per share of 44.97. EBITDA reached 379.94M, while operating income came in at 306.03M.

Over the twelve months ended June 30, 2026, Universal Starch-Chem Allied Limited posted a gross margin of 23.54, reflecting its pricing power and cost economics. The operating margin of 5.95 and net profit margin of 3.67 provide insight into operational efficiency.